Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances

Nat Rev Rheumatol. 2017 Sep;13(9):548-560. doi: 10.1038/nrrheum.2017.124. Epub 2017 Aug 3.


First described in the early 1980s, antiphospholipid syndrome (APS) is a unique form of acquired autoimmune thrombophilia in which patients present with clinical features of recurrent thrombosis and pregnancy morbidity and persistently test positive for the presence of antiphospholipid antibodies (aPL). At least one clinical (vascular thrombosis or pregnancy morbidity) and one lab-based (positive test result for lupus anticoagulant, anticardiolipin antibodies and/or anti-β2-glycoprotein 1 antibodies) criterion have to be met for a patient to be classified as having APS. However, the clinical spectrum of APS encompasses additional manifestations that can affect many organs and cannot be explained exclusively by patients being in a prothrombotic state; clinical manifestations not listed in the classification criteria (known as extra-criteria manifestations) include neurologic manifestations (chorea, myelitis and migraine), haematologic manifestations (thrombocytopenia and haemolytic anaemia), livedo reticularis, nephropathy and valvular heart disease. Increasingly, research interest has focused on the development of novel assays that might be more specific for APS than the current aPL tests. This Review focuses on the current classification criteria for APS, presenting the role of extra-criteria manifestations and lab-based tests. Diagnostic approaches to difficult cases, including so-called seronegative APS, are also discussed.

Publication types

  • Review

MeSH terms

  • Antibodies, Antiphospholipid / drug effects
  • Antibodies, Antiphospholipid / immunology*
  • Antiphospholipid Syndrome / diagnosis*
  • Antiphospholipid Syndrome / immunology*
  • Antiphospholipid Syndrome / therapy
  • Diagnostic Tests, Routine / methods
  • Female
  • Humans
  • Male
  • Needs Assessment
  • Sensitivity and Specificity
  • Severity of Illness Index


  • Antibodies, Antiphospholipid